All In MedTech

FDA Clearance Tracker · P100016-S009

CT LUCIA 621P

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 7, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 7, 2023

Approved

Time to decision

533 days

Received Aug 23, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100016-S009
Device name
CT LUCIA 621P
Applicant location
Ontario, CA
Received
Aug 23, 2021
Decided
Feb 7, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100016

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

Approval for a new product model, CT LUCIA 621P, which is a design change to the currently approved product CT LUCIA 611P.

Source documents

Other decisions for Carl Zeiss Meditec Production, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.